[Cholangiocellular carcinoma--clinical features and surgical treatment]

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Context:

• Cholangiocellular carcinoma (CCC) represents 7-10% of primary liver cancers, second only to hepatocellular carcinoma (80-85%).
• Understanding the distinct clinical and pathological features of CCC is crucial for effective management.
• This study focuses on a cohort of patients diagnosed and treated for primary liver cancer.

Purpose:

• To highlight the differences in clinical and pathological characteristics of cholangiocellular carcinoma compared to other liver tumors.
• To evaluate the outcomes of surgical and non-surgical interventions for cholangiocarcinoma.
• To identify optimal therapeutic strategies for cholangiocarcinoma patients.

Summary:

• A series of 105 primary liver cancer patients operated between 1991-2002 included 9 (8.5%) with cholangiocarcinoma (CCC).
• The CCC cohort comprised 5 males and 4 females with a mean age of 51. Treatments included hepatic resection (5), biliary drainage (1), and explorative laparotomy (3).
• Postoperative mortality by day 30 was zero for resected patients versus one in the drained group. Morbidity included ascites, hepatocellular insufficiency, and fever. One patient achieved over 4 years of survival.

Impact:

• Cholangiocarcinoma can affect younger individuals and often presents asymptomatically, leading to large tumor size at diagnosis.
• Hepatic resection is identified as the most effective therapeutic option for nonjaundiced cholangiocarcinoma patients.
• Findings contribute to the understanding of CCC presentation and guide treatment decisions, emphasizing surgical intervention for resectable cases.